The Combined Impact of a Structured Tai Chi Exercise Program on Selected Clinical Aspects and Quality of Life of Patients With Multiple Sclerosis

CompletedNot a drug-phase studyMS (type not specified)NCT05474209

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What was tested

Treatment tested

  • "Tai-chi" - a special program for patients with multiple sclerosis - once a week training with a Tai Chi instructor lasting 90 minutes

What it measured

Main measures

  • V0 visit- Static posturography

    1. day

  • V1 visit- Static posturography

    3 months after V0 visit

  • V2 visit- Static posturography

    6 months after V0 visit

  • V3 visit- Static posturography

    9 months after V0 visit

  • V4 visit- Static posturography

    12 months after V0 visit

  • V0 visit- Static posturography LI

    1. day

  • V1 visit- Static posturography LI

    3 months after V0 visit

  • V2 visit- Static posturography LI

    6 months after V0 visit

  • V3 visit- Static posturography LI

    9 months after V0 visit

  • V4 visit- Static posturography LI

    12 months after V0 visit

  • V0 visit- Static posturography TA

    1. day

  • V1 visit- Static posturography TA

    3 months after V0 visit

  • V2 visit- Static posturography TA

    6 months after V0 visit

  • V3 visit- Static posturography TA

    9 months after V0 visit

  • V4 visit- Static posturography TA

    12 months after V0 visit

  • V0 visit- Static posturography RMS

    1. day

  • V1 visit- Static posturography RMS

    3 months after V0 visit

  • V2 visit- Static posturography RMS

    6 months after V0 visit

  • V3 visit- Static posturography RMS

    9 months after V0 visit

  • V4 visit- Static posturography RMS

    12 months after V0 visit

  • V0 visit- Mini-BESTest

    1. day

    Walking and mobility
  • V1 visit- Mini-BESTest

    3 months after V0 visit

    Walking and mobility
  • V2 visit- Mini-BESTest

    6 months after V0 visit

    Walking and mobility
  • V3 visit- Mini-BESTest

    9 months after V0 visit

    Walking and mobility
  • V4 visit- Mini-BESTest

    12 months after V0 visit

    Walking and mobility

Other measures (50)

  • V0 visit- EDSS - Expanded disability status scale

    1. day

    Disability progression
  • V1 visit- EDSS - Expanded disability status scale

    3 months after V0 visit

    Disability progression
  • V2 visit- EDSS - Expanded disability status scale

    6 months after V0 visit

    Disability progression
  • V3 visit- EDSS - Expanded disability status scale

    9 months after V0 visit

    Disability progression
  • V4 visit- EDSS - Expanded disability status scale

    12 months after V0 visit

    Disability progression
  • V0 visit- T25FW - Timed 25-foot walk test

    1. day

    Disability progressionWalking and mobility
  • V1 visit- T25FW - Timed 25-foot walk test

    3 months after V0 visit

    Disability progressionWalking and mobility
  • V2 visit- T25FW - Timed 25-foot walk test

    6 months after V0 visit

    Disability progressionWalking and mobility
  • V3 visit- T25FW - Timed 25-foot walk test

    9 months after V0 visit

    Disability progressionWalking and mobility
  • V4 visit- T25FW - Timed 25-foot walk test

    12 months after V0 visit

    Disability progressionWalking and mobility

Who could take part

MS (type not specified) · 20 to 60

Show the full criteria

Inclusion criteria

1. clinically defined MS, 2. age from 20 to 60 years, 3. and the ability to stand and walk independently at least 200 meters without an assistive device.

Exclusion criteria

1. clinical MS exacerbation during the study, 2. disease-modifying drug change during the study, 3. pregnancy, 4. involvement in any other exercise programme, 5. severe cognitive deficit (defined by Montreal Cognitive Assessment score ≤19), and 6. any other health condition that would interfere with an exercise programme (such as musculoskeletal disorder, lung, or heart disease).

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease of the central nervous system (CNS). The clinical picture is very variable, ultimately resulting in disability. Disease attacks manifest themselves depending on the location of the CNS damaged by inflammation, demyelination, axonal loss and gliosis. The most common manifestations include motor disorders with the development of stiffness, balance and coordination, cognition, fatigue and depression. In the long term, most patients with MS will achieve significant and irreversible incapacitation. Immunomodulatory therapy is designed to reduce disease activity, slowing progression, but only to a certain extent. A significant benefit, but little researched, is physical exercise. Tai Chi has a positive effect on various neurological diseases. In recent studies, Tai Chi has shown improvements in coordination and balance, depression, anxiety, cognition and overall quality of life in patients with MS. The aim of the project is to assess the therapeutic value of structured Tai Chi exercise based on published clinical work.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jan 2019

    2. Main results due

      Jan 2020

    3. Finished

      Jan 2022

    Assembled by software from public sources.